Search

Author/Creator Michetti, P.

1. Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience. Issue 5 (8th January 2018)

Authors:
Wils, P.; Bouhnik, Y.; Michetti, P.; Flourie, B.; Brixi, H.; Bourrier, A.; Allez, M.; Duclos, B.; Serrero, M.; Buisson, A.; Amiot, A.; Fumery, M.; Roblin, X.; Peyrin‐Biroulet, L.; Filippi, J.; Bouguen, G.; Abitbol, V.; Coffin, B.; Simon, M.; Laharie, D.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 5(2018)
Page Start:
588
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. FRI0198 Multi-Country, Cross-Sectional Study to Determine Patient-Specific and General Beliefs towards Medication and their Treatment Adherence to Selected Systemic Therapies in 6 Chronic Immune-Mediated Inflammatory Diseases (ALIGN). (10th June 2014)

Authors:
Michetti, P.; Weinman, J.; Mrowietz, U.; Smolen, J.; Schremmer, D.; Tundia, N.; Gillas, F.; Selenko-Gebauer, N.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
454
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron‐containing medicines. Issue 7 (April 2014)

Authors:
Gomollón, F.; Chowers, Y.; Danese, S.; Dignass, A.; Haagen Nielsen, O.; Lakatos, P. L.; Lees, C. W.; Lindgren, S.; Lukas, M.; Mantzaris, G. J.; Michetti, P.; Moum, B.; Peyrin‐Biroulet, L.; Toruner, M.; van der, J.; Weiss, G.; Stoevelaar, H.; Reinisch, W.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 39:Issue 7(2014)
Page Start:
743
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method. Issue 9 (17th September 2013)

Authors:
Reinisch, W.; Chowers, Y.; Danese, S.; Dignass, A.; Gomollón, F.; Haagen Nielsen, O.; Lakatos, P. L.; Lees, C. W.; Lindgren, S.; Lukas, M.; Mantzaris, G. J.; Michetti, P.; Moum, B.; Peyrin‐Biroulet, L.; Toruner, M.; van der, J.; Weiss, G.; Stoevelaar, H.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 38:Issue 9(2013)
Page Start:
1109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The gap between scientific evidence and clinical practice: 5‐aminosalicylates are frequently used for the treatment of Crohn's disease. Issue 8 (22nd August 2014)

Authors:
Schoepfer, A. M.; Bortolotti, M.; Pittet, V.; Mottet, C.; Gonvers, J.‐J.; Reich, O.; Fournier, N.; Vader, J.‐P.; Burnand, B.; Michetti, P.; Froehlich, F.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 40:Issue 8(2014)
Page Start:
930
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. ALIGNed on adherence: subanalysis of adherence in immune‐mediated inflammatory diseases in the DACH region of the global ALIGN study. (22nd August 2018)

Authors:
Kolios, A.G.A.; Hueber, A.J.; Michetti, P.; Mrowietz, U.; Mustak‐Blagusz, M.; Sator, P.‐G.; Reinshagen, M.; Wilsmann‐Theis, D.; Gomis‐Kleindienst, S.; Luckey, U.; Rössler, A.; Schiefke, I.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 33:Number 1(2019)
Page Start:
234
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗